193 related articles for article (PubMed ID: 18258695)
1. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.
Needham M; James I; Corbett A; Day T; Christiansen F; Phillips B; Mastaglia FL
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1056-60. PubMed ID: 18258695
[TBL] [Abstract][Full Text] [Related]
2. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
Mastaglia FL; Needham M; Scott A; James I; Zilko P; Day T; Kiers L; Corbett A; Witt CS; Allcock R; Laing N; Garlepp M; Christiansen FT
Neuromuscul Disord; 2009 Nov; 19(11):763-5. PubMed ID: 19720533
[TBL] [Abstract][Full Text] [Related]
3. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.
Price P; Santoso L; Mastaglia F; Garlepp M; Kok CC; Allcock R; Laing N
Tissue Antigens; 2004 Nov; 64(5):575-80. PubMed ID: 15496200
[TBL] [Abstract][Full Text] [Related]
4. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis.
Needham M; Corbett A; Day T; Christiansen F; Fabian V; Mastaglia FL
J Clin Neurosci; 2008 Dec; 15(12):1350-3. PubMed ID: 18815046
[TBL] [Abstract][Full Text] [Related]
6. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families.
Sivakumar K; Semino-Mora C; Dalakas MC
Brain; 1997 Apr; 120 ( Pt 4)():653-61. PubMed ID: 9153127
[TBL] [Abstract][Full Text] [Related]
7. Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.
Mastaglia FL
Acta Myol; 2009 Oct; 28(2):66-71. PubMed ID: 20128139
[TBL] [Abstract][Full Text] [Related]
8. High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: an analysis of disease-associated alleles and diplotypes.
Rojana-udomsart A; James I; Castley A; Needham M; Scott A; Day T; Kiers L; Corbett A; Sue C; Witt C; Martinez P; Christiansen F; Mastaglia F
J Neuroimmunol; 2012 Sep; 250(1-2):77-82. PubMed ID: 22633068
[TBL] [Abstract][Full Text] [Related]
9. Sporadic Inclusion Body Myositis Manifesting as Isolated Muscle Weakness of the Finger Flexors Three Years after Disease Onset.
Suwa Y; Suzuki N; Soga T; Harada R; Shibui A; Kuroda H; Izumi R; Tateyama M; Nakashima I; Sonoo M; Aoki M
Intern Med; 2016; 55(23):3521-3524. PubMed ID: 27904121
[TBL] [Abstract][Full Text] [Related]
10. Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients.
Badrising UA; Maat-Schieman ML; van Houwelingen JC; van Doorn PA; van Duinen SG; van Engelen BG; Faber CG; Hoogendijk JE; de Jager AE; Koehler PJ; de Visser M; Verschuuren JJ; Wintzen AR
J Neurol; 2005 Dec; 252(12):1448-54. PubMed ID: 15942703
[TBL] [Abstract][Full Text] [Related]
11. Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study.
Phillips BA; Cala LA; Thickbroom GW; Melsom A; Zilko PJ; Mastaglia FL
Muscle Nerve; 2001 Nov; 24(11):1526-34. PubMed ID: 11745956
[TBL] [Abstract][Full Text] [Related]
12. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
Kierdaszuk B; Berdynski M; Palczewski P; Golebiowski M; Zekanowski C; Kaminska AM
Folia Neuropathol; 2015; 53(4):355-66. PubMed ID: 26785370
[TBL] [Abstract][Full Text] [Related]
13. Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis.
Allenbach Y; Benveniste O; Decostre V; Canal A; Eymard B; Herson S; Bloch-Queyrat C; Hogrel JY
Neuromuscul Disord; 2012 Nov; 22(11):980-6. PubMed ID: 22738680
[TBL] [Abstract][Full Text] [Related]
14. Sporadic inclusion body myositis presenting with severe camptocormia.
Ma H; McEvoy KM; Milone M
J Clin Neurosci; 2013 Nov; 20(11):1628-9. PubMed ID: 24055211
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features of sporadic inclusion body myositis in China.
Li K; Pu C; Huang X; Liu J; Mao Y; Lu X
Neurol Neurochir Pol; 2015; 49(4):245-50. PubMed ID: 26188941
[TBL] [Abstract][Full Text] [Related]
16. Distal muscle involvement in granulomatous myositis can mimic inclusion body myositis.
Larue S; Maisonobe T; Benveniste O; Chapelon-Abric C; Lidove O; Papo T; Eymard B; Dubourg O
J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):674-7. PubMed ID: 20562458
[TBL] [Abstract][Full Text] [Related]
17. Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52.1.
Scott AP; Allcock RJ; Mastaglia F; Nishino I; Nonaka I; Laing N
Neuromuscul Disord; 2006 May; 16(5):311-5. PubMed ID: 16564169
[TBL] [Abstract][Full Text] [Related]
18. Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis.
Rojana-udomsart A; Mitrpant C; James I; Witt C; Needham M; Day T; Kiers L; Corbett A; Martinez P; Wilton SD; Mastaglia FL
J Neuroimmunol; 2013 Jan; 254(1-2):174-7. PubMed ID: 23010279
[TBL] [Abstract][Full Text] [Related]
19. Inclusion-body myositis presenting with facial diplegia.
Ghosh PS; Laughlin RS; Engel AG
Muscle Nerve; 2014 Feb; 49(2):287-9. PubMed ID: 24038039
[TBL] [Abstract][Full Text] [Related]
20. Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex.
Scott AP; Laing NG; Mastaglia F; Needham M; Walter MC; Dalakas MC; Allcock RJ
J Neuroimmunol; 2011 Jun; 235(1-2):77-83. PubMed ID: 21543121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
